Optiver Holding
UTMD icon

Optiver Holding’s Utah Medical Products UTMD Stock Holding History

Optiver Holding’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138 Sell
2
-24
-92% -$1.59K ﹤0.01% 2631
2026
Q1 		$1.61K Sell
26
-8
-24% -$504 ﹤0.01% 1935
2025
Q4 		$1.9K Hold
34
– – ﹤0.01% 2044
2025
Q3 		$2.14K Buy
+34
New +$2.01K ﹤0.01% 2362

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optiver Holding's UTMD Position: Q2 2026 in Review

Optiver Holding reduced its Utah Medical Products (UTMD) stake by 92% in Q2 2026, selling an estimated $1.59K and leaving 2 shares worth $138. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

Optiver Holding first reported a position in UTMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.14K in Q3 2025. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Optiver Holding held 2 shares of Utah Medical Products worth $138 as of Q2 2026.
  • Optiver Holding sold 24 Utah Medical Products shares in Q2 2026, an estimated $1.59K.
  • Utah Medical Products made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2631 holding.
  • Optiver Holding first reported a position in Utah Medical Products in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Utah Medical Products position peaked at $2.14K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.